JP2006505577A5 - - Google Patents

Download PDF

Info

Publication number
JP2006505577A5
JP2006505577A5 JP2004546105A JP2004546105A JP2006505577A5 JP 2006505577 A5 JP2006505577 A5 JP 2006505577A5 JP 2004546105 A JP2004546105 A JP 2004546105A JP 2004546105 A JP2004546105 A JP 2004546105A JP 2006505577 A5 JP2006505577 A5 JP 2006505577A5
Authority
JP
Japan
Prior art keywords
exacerbated
prevention
treatment
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004546105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505577A (ja
JP4599164B2 (ja
Filing date
Publication date
Priority claimed from FR0213270A external-priority patent/FR2846330B1/fr
Application filed filed Critical
Publication of JP2006505577A publication Critical patent/JP2006505577A/ja
Publication of JP2006505577A5 publication Critical patent/JP2006505577A5/ja
Application granted granted Critical
Publication of JP4599164B2 publication Critical patent/JP4599164B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004546105A 2002-10-23 2003-10-21 ３位が複素環式基によって置換されたピリドインドロン誘導体、それらの製造法およびそれらの治療用途 Expired - Fee Related JP4599164B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213270A FR2846330B1 (fr) 2002-10-23 2002-10-23 Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
PCT/FR2003/003111 WO2004037821A1 (fr) 2002-10-23 2003-10-21 Derives de pyridoindolone substitues en -3 par un groupe heterocyclique, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
JP2006505577A JP2006505577A (ja) 2006-02-16
JP2006505577A5 true JP2006505577A5 (https=) 2006-12-07
JP4599164B2 JP4599164B2 (ja) 2010-12-15

Family

ID=32088226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004546105A Expired - Fee Related JP4599164B2 (ja) 2002-10-23 2003-10-21 ３位が複素環式基によって置換されたピリドインドロン誘導体、それらの製造法およびそれらの治療用途

Country Status (13)

Country Link
EP (1) EP1556380B1 (https=)
JP (1) JP4599164B2 (https=)
AR (1) AR041690A1 (https=)
AT (1) ATE323091T1 (https=)
AU (1) AU2003292285A1 (https=)
CY (1) CY1105158T1 (https=)
DE (1) DE60304596T2 (https=)
DK (1) DK1556380T3 (https=)
ES (1) ES2263033T3 (https=)
FR (1) FR2846330B1 (https=)
PT (1) PT1556380E (https=)
TW (1) TW200418853A (https=)
WO (1) WO2004037821A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
US12122780B2 (en) * 2019-02-01 2024-10-22 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Pyrimidinyl group-containing tricyclic compound serving as c-Met inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique

Similar Documents

Publication Publication Date Title
JP2003503454A5 (https=)
EP1979324A4 (en) IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF COGNITIVE DISORDER, MORBUS ALZHEIMER, NEURODEGENERATION AND DEMENTIA.
WO2006032342A3 (de) Arzneimittel enthaltend carbonylverbindungen sowie deren verwendung
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
AP2006003596A0 (en) A pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases.
WO2007122580A3 (en) Compositions of phenylephrine useful for treatment of respiratory illness
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
EP1940373B8 (en) 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease
CL2007003690A1 (es) Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas.
JP2007520565A5 (https=)
JP2007523135A5 (https=)
JP2003526626A5 (https=)
NO20076405L (no) Anvendelse av 24-nor-UDCA
JP2008513510A5 (https=)
WO2006004449A3 (en) A combination composition
JP2005511748A5 (https=)
IL185300A0 (en) New pharmaceutical compositions useful in the treatment of parkinson's disease
JP2005509503A5 (https=)
JP2008513426A5 (https=)
JP2008515980A5 (https=)
JP2006505577A5 (https=)
JP2008513427A5 (https=)
WO2006108681A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against bacteria